FGF21 and Parkinson disease: In the current study, we provided the first evidence that FGF21 treatment alleviated motor and cognitive function in PD mice via modulating gut microbiota and maintaining gut–brain metabolic homeostasis, benefiting from comprehensive investigations on neuronal function, gut microbiota profiling, brain‐region specific metabolic homeostasis, and metabolic profiling in the colon.